Investigation of Efficacy of Botulinum Toxin A (Dysport) in Chronic Low Back Pain
Phase of Trial: Phase II
Latest Information Update: 22 Jul 2016
Price : $35 *
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Back pain
- Focus Therapeutic Use
- Sponsors Ipsen Biopharmaceuticals
- 09 Feb 2016 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 13 Apr 2015 Planned End Date changed from 1 Dec 2015 to 1 Jul 2016 as reported by ClinicalTrials.gov record.
- 13 Apr 2015 Planned primary completion date changed from 1 Dec 2014 to 1 Jul 2016 as reported by ClinicalTrials.gov record.